NEW YORK (GenomeWeb) – Provista Diagnostics said today that its Scottsdale Ariz.-based CLIA-certified laboratory has received accreditation from the College of American Pathologists.
Provista is a molecular diagnostics firm focused on blood-based proteomic tests for disease including breast and ovarian cancer. Additionally, the company offers diagnostic development services to outside firms through its CLIA facility.
"For development of our own proprietary diagnostics, as well as our work developing companion diagnostics for other companies, CAP accreditation signifies additional assurance that our lab operates under the highest quality standards to generate highly accurate and reliable results." Provista President and CEO David Reese said in a statement.
The CAP Laboratory Accreditation Program involves inspections of clinical lab records and quality control procedures and assessments of a lab's staff qualifications, equipment, facilities, safety program, and overall management.